

Thyroid cancer new drug lenvatinib is bringing hope to patients with a progression-free survival almost five times more in people

A U.S. study has found out that thyroid cancer cases have tripled since 1975, but it also determined researchers to

Slow-growing tumors are reason for concern, but too often they result in the overdiagnosis of thyroid cancer, which leads to